BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Impliant Ltd. Awarded Two Key US Patents For Spine Motion Preservation


5/8/2006 10:51:03 AM

MILFORD, Connecticut, May 8 /PRNewswire/ -- Impliant, Inc. (www.impliant.com), a developer of novel spine arthroplasty alternatives to fusion surgery, today announced that its wholly-owned subsidiary, Impliant, Ltd., has been awarded two United States patents for its spinal implant solutions in posterior motion preservation.

Ron Sacher, Chief Executive Officer of Impliant, said, "We are pleased that the United States Patent and Trademark Office has recognized the ingenuity of the TOPS(TM) System. These medical device patents are strategic assets for the Company as we continue to build our leadership position in the posterior spine motion preservation market with Impliant's Total Posterior Arthroplasty solution."

The first patent (U.S. Patent No. 6,966,930) is a minimally invasive facet repair system that allows surgeons to implant a spacer between the posterior joints of the spine. The spinal implant device is intended to alleviate isolated facet joint pain due to joint space narrowing-a degenerative spinal condition associated with facet arthrosis.

The second patent (U.S. Patent No. 7,011,685) is the basis for Impliant's TOPS(TM) System-a novel three-axes Total Posterior Arthroplasty solution. The TOPS(TM) System, an alternative to spinal fusion, is designed to stabilize but not fuse the affected vertebral level after a laminectomy and medial facetectomy to alleviate pain stemming from degenerative spondylolisthesis, spinal stenosis, and facet arthrosis.

Impliant has the longest series of patents for these broad posterior indications that have been successfully treated with a motion preservation device. The patented TOPS(TM) System is currently being investigated in leading centers around the world.

About the TOPS(TM) System

Impliant's TOPS(TM) System, a mobile posterior device, is designed to stabilize but not fuse the affected vertebral level to alleviate pain stemming from degenerative facet arthrosis, spondylolisthesis, and spinal stenosis. Following a laminectomy and medial facetectomy, the device is affixed to the spine via four pedicle screws using a standard posterior surgical approach. Impliant believes that the TOPS(TM) System could benefit 300,000 patients worldwide undergoing spinal fusion surgery each year. The TOPS(TM) System is not approved for sale or use in the United States.

About Impliant, Inc.

Impliant, Inc. is a privately held company engaged in the development of novel spine arthroplasty solutions. The company is currently developing the TOPS(TM) System, which is designed to alleviate pain resulting from degenerative facet arthrosis, spondylolisthesis, and spinal stenosis by stabilizing but not fusing the affected vertebral level. Impliant is headquartered in Milford, CT with research facilities located in Ramat Poleg, Israel. For more information about Impliant, please visit www.impliant.com.

Contacts: Ron Sacher, CEO Todd Potokar, President +917-270-5538 +1-203-877-8884 rsacher@impliant.comtpotokar@impliant.com

Impliant Ltd

CONTACT: Ron Sacher, CEO, +917-270-5538, rsacher@impliant.com, ToddPotokar, President, +1-203-877-8884, tpotokar@impliant.com



Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES